Dendritic cells: potential triggers of autoimmunity and targets for therapy
Dendritic cells: potential triggers of autoimmunity and targets for therapy
复制标题
DOI:
10.1136/ard.2005.044560
复制
发表时间:
2005-11-01
影响因子:
27.4
通讯作者:
Hardin, JA
中科院分区:
文献类型:
--
作者:
Hardin, JA
Dendritic cells (DCs) are often referred to as the body’s sentinels, constantly guarding against pathogens. 1–3 In this role they are the antigen presenting cell that primes naive T cells in vivo. 4 DCs also help maintain tolerance to ‘‘self’’substances through multiple mechanisms that include T cell deletion and anergy as well as the generation of regulatory T cells. 5–7 This dual role in regulating both immune responses and immune tolerance suggests that DCs are likely to have a role in autoimmune diseases such as lupus. The possibilities include presentation of ‘‘self’’antigens as immunogens, a failure to delete autoreactive T cells, overproduction of inflammatory cytokines, and inadequate induction of regulatory T cells. As noted below, insights into these pathogenetic mechanisms in lupus are beginning to emerge. It is also clear that at least some of these activities of DCs can be manipulated through pharmacological agents. 8 9 It has been thought for a long time that regulatory T cells are related to the pathogenesis of lupus. 10 11 Now, at the forefront of this consideration is the possibility that DCs play a critical role in balancing the array of autoreactive T cells with a corresponding set of regulatory T cells. 12 It is clear that immature DCs induce deletional tolerance of autoreactive T cells in the periphery. 13–15 However, the original concept that immature DCs are responsible for tolerance and mature DCs induce immune responses has given way to a more complex scenario in which DCs in different states of maturation are able to induce CD4+ CD25+ regulatory T cells. 16 17 In this paper, my aim is to consider the possibility that the maturation of DCs might be manipulated in such a way as to either enhance regulatory T cell generation or diminish priming of autoreactive effector T cells in patients with lupus.DC SUBSETS As illustrated in fig 1 and reviewed in reference 20, DCs derive from two sources, stem cells in the bone marrow and precursor cells found in the circulation. It is likely that there are multiple subtypes—differing in molecular characteristics and functional properties—within each of the four major groups of DCs shown here. It remains unclear to what extent these subspecies arise through differences in lineage or in response to environmental stimuli such as cytokines. 20–23 Langerhans’ cells are characterised by the presence of Birbeck’s granules as well as expression of langerin. Since these cells reside within the epidermis they are poised to have the first interaction with an invading pathogen. 24 25 Langerhans’ cells have several specialised properties. Firstly, langerin and its associated Birbeck’s granules are thought to represent an antigen uptake system unique to these cells. 26 Secondly, they are thought to be uniquely designed to transport antigens from the dermis to regional lymph nodes27 and they may be more focused on generating exclusively T helper (Th) 1 responses because of their lack of interleukin (IL)-10 secretion. 28 Finally, these cells contribute to, but are not essential for, contact hypersensitivity. 29 It is possible these